The Efficacy and Safety of Adjuvant Lomustine to Chemotherapy for Recurrent Glioblastoma: A Meta-analysis of Randomized Controlled Studies
Conclusions
Adjuvant lomustine to other chemotherapy may provide no obvious benefits for the treatment of recurrent glioblastoma.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Original Articles Source Type: research
More News: Brain | Chemotherapy | Databases & Libraries | Neurology | Neuroscience | Science | Study